Search Results for: covid-19
Articles
Relief Therapeutics & NeuroRx Expand Clinical Trial of COVID-19 Drug June 11, 2020
Relief Therapeutics and its US partner, NeuroRx, Inc. recently announced that the Phase 2/3 clinical trial evaluating RLF-100 as a treatment for critical COVID-19 with…
Immunic Announces FDA Allowance of its Phase 2 Trial of COVID-19 Drug June 10, 2020
Immunic, Inc. recently announced receipt of regulatory allowance from the US FDA to initiate its Phase 2, CALVID-1 clinical trial...FORMULATION FORUM - Application of Captisol® Technology to Enable the Formulation of Remdesivir in Treating COVID-19 June 4, 2020
James Pipkin, PhD, Vince Antle, PhD, and Rebecca Garcia-Fandiño, PhD, explain why more Captisol® than ever is required to meet Gilead’s bold goals of making remdesivir available to COVID-19 patients in the US and to hundreds of countries around the world.
Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase 2 Study June 2, 2020
Atriva Therapeutics GmbH recently announced a clinical strategy to treat patients with moderate to severe COVID-19 who require hospitalization. ATR-002,...ARCA Biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy June 2, 2020
ARCA biopharma, Inc. recently announced a new development program to evaluate AB201 (rNAPc2), a potent, selective inhibitor of tissue factor...Apellis Initiates Phase 1/2 Study of APL-9 in Patients With Severe COVID-19 June 2, 2020
Apellis Pharmaceuticals, Inc. recently announced the company has initiated a Phase 1/2 clinical study of APL-9, an investigational C3 inhibitor...Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement With Humanigen for Lenzilumab, Currently in FDA-Approved Phase 3 Study for COVID-19 May 26, 2020
Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, recently announced it has entered into a...Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate May 26, 2020
Vaxart, Inc. recently announced it has selected its lead COVID-19 vaccine candidate and has contracted with KindredBio to manufacture bulk...FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients May 26, 2020
The US FDA has recently approved the investigational new drug (IND) application submitted by Octapharma USA for a Phase 3 clinical trial on…
CanSino Biologics & Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine May 20, 2020
CanSino Biologics Inc. and Precision NanoSystems (PNI) recently announced a co-development agreement of a mRNA lipid nanoparticle (mRNA-LNP) vaccine against COVID-19. The parties will…
CureVac´s Optimized mRNA Platform Provides Positive PreClinical Results at Low Dose for COVID-19 Vaccine Candidate May 19, 2020
CureVac AG recently announced positive preclinical results at a low dose for its lead vaccine candidate against the novel Coronavirus...COVID-19’s Effect Will Boost Infectious Disease Drug Approvals & Present Opportunities to CMOs May 19, 2020
In response to the global pandemic, biopharma companies have put a renewed emphasis on finding treatments for infectious diseases, including COVID-19 and other infectious diseases overall…..
Akers Biosciences & Premas Biotech Announce Successful Completion of COVID-19 Vaccine Prototype & Obtained First Images of VLP May 19, 2020
Akers Biosciences, Inc. recently announced that Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic…..
Catalent Partners With Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19 May 13, 2020
Catalent recently welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its previously announced...Evelo Biosciences, Rutgers University & Robert Wood Johnson University Hospital Announce Submission of IND for Phase 2 Study of EDP1815 in COVID-19 Patients May 13, 2020
Evelo Biosciences, Inc., Rutgers University, and Robert Wood Johnson University Hospital recently announced the submission of an Investigational New Drug...AI VIVO Seeks Collaboration Partners to Progress Top-Ranked COVID-19 Therapeutic Candidates May 13, 2020
AI VIVO recently announced it is seeking pharma and biotech collaboration partners to progress therapeutic candidates that have been identified...Singota Solutions Collaborates With Noveome Biotherapeutics to Manufacture Promising Therapy to Treat Severe Condition in People Infected with COVID-19 May 13, 2020
Singota Solutions has been selected to collaborate with Noveome Biotherapeutics, Inc. to manufacture the ST266 investigational drug product, a biologic being evaluated in….
Proveris Scientific Announces Contract Test Services to Support Development of SARS-CoV-2 (COVID-19) Inhaled Drug Therapies & Vaccines May 6, 2020
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced the availability of contract test services to support….
Arcturus Therapeutics & Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine May 5, 2020
Arcturus Therapeutics Holdings Inc. and Catalent, Inc.recently announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to….
Almac Group’s Comprehensive Service Offerings to Support Expedited COVID-19 Research Programs & Treatments April 30, 2020
Almac Group is an established contract development and manufacturing organization (CDMO) providing an extensive range of integrated services across the...
